-
Je něco špatně v tomto záznamu ?
Ellagic Acid Affects Metabolic and Transcriptomic Profiles and Attenuates Features of Metabolic Syndrome in Adult Male Rats
A. Kábelová, H. Malínská, I. Marková, O. Oliyarnyk, B. Chylíková, O. Šeda
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
GAUK 1132218
Grantová Agentura, Univerzita Karlova
PROGRES-Q25/LF1, SVV 260516
Univerzita Karlova v Praze
64165, General University Hospital in Prague
Ministerstvo Zdravotnictví Ceské Republiky
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
33671116
DOI
10.3390/nu13030804
Knihovny.cz E-zdroje
- MeSH
- biologické markery analýza MeSH
- dieta s vysokým obsahem tuků MeSH
- epididymis MeSH
- hnědá tuková tkáň chemie MeSH
- játra chemie MeSH
- krevní glukóza analýza MeSH
- krysa rodu rattus MeSH
- kyselina ellagová aplikace a dávkování MeSH
- messenger RNA analýza MeSH
- metabolický syndrom genetika metabolismus prevence a kontrola MeSH
- oxidační stres účinky léků MeSH
- potkani inbrední SHR MeSH
- RNA analýza MeSH
- transkriptom účinky léků MeSH
- tuková tkáň chemie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Ellagic acid, a natural substance found in various fruits and nuts, was previously shown to exhibit beneficial effects towards metabolic syndrome. In this study, using a genetic rat model of metabolic syndrome, we aimed to further specify metabolic and transcriptomic responses to ellagic acid treatment. Adult male rats of the SHR-Zbtb16Lx/k.o. strain were fed a high-fat diet accompanied by daily intragastric gavage of ellagic acid (50 mg/kg body weight; high-fat diet-ellagic acid (HFD-EA) rats) or vehicle only (high-fat diet-control (HFD-CTL) rats). Morphometric and metabolic parameters, along with transcriptomic profile of liver and brown and epididymal adipose tissues, were assessed. HFD-EA rats showed higher relative weight of brown adipose tissue (BAT) and decreased weight of epididymal adipose tissue, although no change in total body weight was observed. Glucose area under the curve, serum insulin, and cholesterol levels, as well as the level of oxidative stress, were significantly lower in HFD-EA rats. The most differentially expressed transcripts reflecting the shift induced by ellagic acid were detected in BAT, showing downregulation of BAT activation markers Dio2 and Nr4a1 and upregulation of insulin-sensitizing gene Pla2g2a. Ellagic acid may provide a useful nutritional supplement to ameliorate features of metabolic syndrome, possibly by suppressing oxidative stress and its effects on brown adipose tissue.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019186
- 003
- CZ-PrNML
- 005
- 20231213092952.0
- 007
- ta
- 008
- 210728s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/nu13030804 $2 doi
- 035 __
- $a (PubMed)33671116
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kábelová, Adéla $u Institute of Biology and Medical Genetics, the First Faculty of Medicine, Charles University and the General University Hospital, Prague 121 08, Czech Republic
- 245 10
- $a Ellagic Acid Affects Metabolic and Transcriptomic Profiles and Attenuates Features of Metabolic Syndrome in Adult Male Rats / $c A. Kábelová, H. Malínská, I. Marková, O. Oliyarnyk, B. Chylíková, O. Šeda
- 520 9_
- $a Ellagic acid, a natural substance found in various fruits and nuts, was previously shown to exhibit beneficial effects towards metabolic syndrome. In this study, using a genetic rat model of metabolic syndrome, we aimed to further specify metabolic and transcriptomic responses to ellagic acid treatment. Adult male rats of the SHR-Zbtb16Lx/k.o. strain were fed a high-fat diet accompanied by daily intragastric gavage of ellagic acid (50 mg/kg body weight; high-fat diet-ellagic acid (HFD-EA) rats) or vehicle only (high-fat diet-control (HFD-CTL) rats). Morphometric and metabolic parameters, along with transcriptomic profile of liver and brown and epididymal adipose tissues, were assessed. HFD-EA rats showed higher relative weight of brown adipose tissue (BAT) and decreased weight of epididymal adipose tissue, although no change in total body weight was observed. Glucose area under the curve, serum insulin, and cholesterol levels, as well as the level of oxidative stress, were significantly lower in HFD-EA rats. The most differentially expressed transcripts reflecting the shift induced by ellagic acid were detected in BAT, showing downregulation of BAT activation markers Dio2 and Nr4a1 and upregulation of insulin-sensitizing gene Pla2g2a. Ellagic acid may provide a useful nutritional supplement to ameliorate features of metabolic syndrome, possibly by suppressing oxidative stress and its effects on brown adipose tissue.
- 650 _2
- $a tuková tkáň $x chemie $7 D000273
- 650 _2
- $a hnědá tuková tkáň $x chemie $7 D002001
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $x analýza $7 D015415
- 650 _2
- $a krevní glukóza $x analýza $7 D001786
- 650 _2
- $a dieta s vysokým obsahem tuků $7 D059305
- 650 _2
- $a kyselina ellagová $x aplikace a dávkování $7 D004610
- 650 _2
- $a epididymis $7 D004822
- 650 _2
- $a játra $x chemie $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolický syndrom $x genetika $x metabolismus $x prevence a kontrola $7 D024821
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a RNA $x analýza $7 D012313
- 650 _2
- $a messenger RNA $x analýza $7 D012333
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a transkriptom $x účinky léků $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Malínská, Hana $u Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic
- 700 1_
- $a Marková, Irena $u Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic
- 700 1_
- $a Oliyarnyk, Olena $u Institute for Clinical and Experimental Medicine, Prague 140 21, Czech Republic
- 700 1_
- $a Chylíková, Blanka $u Institute of Biology and Medical Genetics, the First Faculty of Medicine, Charles University and the General University Hospital, Prague 121 08, Czech Republic
- 700 1_
- $a Šeda, Ondřej $u Institute of Biology and Medical Genetics, the First Faculty of Medicine, Charles University and the General University Hospital, Prague 121 08, Czech Republic $7 xx0070901
- 773 0_
- $w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 13, č. 3 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33671116 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20231213092948 $b ABA008
- 999 __
- $a ok $b bmc $g 1690093 $s 1139632
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 13 $c 3 $e 20210228 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
- GRA __
- $a GAUK 1132218 $p Grantová Agentura, Univerzita Karlova
- GRA __
- $a PROGRES-Q25/LF1, SVV 260516 $p Univerzita Karlova v Praze
- GRA __
- $a 64165, General University Hospital in Prague $p Ministerstvo Zdravotnictví Ceské Republiky
- LZP __
- $a Pubmed-20210728